Critical care explorations - Crit Care Explor

Publications

  1. 2021
  2. Efficacy and Safety of Vilobelimab (IFX-1), a Novel Monoclonal Anti-C5a Antibody, in Patients With Early Severe Sepsis or Septic Shock - A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase IIa Trial (SCIENS Study)

    Bauer, M., Weyland, A., Marx, G., Bloos, F., Weber, S., Weiler, N., Kluge, S., Diers, A., Simon, T. P., Lautenschläger, I., Gründling, M., Jaschinski, U., Simon, P., Nierhaus, A., Moerer, O., Reill, L., Jörres, A., Guo, R., Loeffler, M., Reinhart, K. & Riedemann, N., 11.2021, In: Critical care explorations. 3, 11, e0577.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review